Discontinuation of Amlodipine for Hypertension
Amlodipine should not be stopped abruptly without prescriber guidance. [1][2]
Discontinuation is generally approached as a monitored deprescribing trial in selected patients with well-controlled blood pressure. [3]
Assessment Before Deprescribing
Deprescribing of antihypertensive therapy is most appropriately considered in patients with well-controlled blood pressure who do not have an immediate clinical reason that mandates continued treatment. [3]
Blood pressure should be monitored regularly after any reduction or cessation attempt. [3]
Patients with high cardiovascular risk or evidence of target-organ damage require careful reassessment of the risk–benefit of stopping therapy. [3]
Medication-Specific Safety Considerations
Amlodipine should not be discontinued suddenly unless directed by a clinician. [1]
Blood pressure medicines can cause rebound or clinically significant worsening when reduced or stopped, so abrupt discontinuation is generally avoided. [2]
Tapering Strategy for Calcium Channel Blockers
Amlodipine dose reduction should be gradual and supervised by a clinician rather than abrupt cessation. [1][2]
A “step-down” (progressive reduction) approach has been evaluated for antihypertensive deprescribing strategies in older adults receiving more than one agent, with follow-up for outcomes and safety. [4]
Monitoring Plan During Dose Reduction and After Stopping
Regular blood pressure monitoring after medication reduction or withdrawal is required to detect loss of control and guide restart decisions. [3]
Home blood pressure measurement can be used for close monitoring during and after tapering, with escalation back to the prior effective regimen if blood pressure control deteriorates. [3]
Indications to Stop the Taper and Resume Treatment
The deprescribing trial should be discontinued and prior effective antihypertensive therapy should be reinstated if blood pressure control is not maintained on the reduced dose. [3]
Common Pitfalls to Avoid
Abrupt stopping of blood pressure medicines is a key safety pitfall and should be avoided. [2]
Clinically meaningful blood pressure worsening can occur after medication withdrawal, so “trial off” strategies require scheduled follow-up rather than self-directed discontinuation. [3]
Practical Transition to Ongoing Hypertension Care
Lifestyle management should continue throughout any deprescribing attempt, while blood pressure targets are reassessed based on measured readings after dose reduction. [3]
Evidence Base for Withdrawal Trials
Systematic review evidence supports offering a monitored withdrawal trial in patients with well-controlled hypertension with subsequent regular blood pressure monitoring. [3]